Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction: Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25)

This publication has 33 references indexed in Scilit:

• From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes The Global Registry of Acute Coronary Events (GRACE)
  European Heart Journal, 2003
• Management of acute myocardial infarction in patients presenting with ST-segment elevation
  European Heart Journal, 2003
• A Comparison of Continuous Infusion of Alteplase with Double-Bolus Administration for Acute Myocardial Infarction
  New England Journal of Medicine, 1997
• A Comparison of Reteplase with Alteplase for Acute Myocardial Infarction
  New England Journal of Medicine, 1997
• TIMI grade 3 flow and reocclusion after intravenous thrombolytic therapy: A pooled analysis
  American Heart Journal, 1997
• A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes
  New England Journal of Medicine, 1996
• Hirudin in Acute Myocardial Infarction
  Circulation, 1996
• An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction
  Published by Elsevier ,1992
• Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.
  Circulation, 1990